Wells Fargo & Company Spruce Biosciences, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.7 - $5.49 $1 - $10	2 Added 1.42%	143 $0
Q4 2023 Feb 09, 2024	BUY	$1.04 - $2.93 $11 - $32	11 Added 8.46%	141 $0
Q3 2023 Nov 13, 2023	SELL	$2.04 - $2.54 $114 - $142	-56 Reduced 30.11%	130 $0
Q2 2023 Aug 15, 2023	BUY	$1.92 - $2.6 $228 - $309	119 Added 177.61%	186 $0
Q1 2023 May 12, 2023	SELL	$1.15 - $3.17 $458 - $1,264	-399 Reduced 85.62%	67 $0
Q4 2022 Feb 13, 2023	SELL	$0.99 - $1.43 $196 - $283	-198 Reduced 29.82%	466 $0
Q3 2022 Nov 14, 2022	SELL	$1.18 - $2.19 $466 - $865	-395 Reduced 37.3%	664 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.23 $4,855 - $8,458	-3,793 Reduced 78.17%	1,059 $2,000
Q1 2022 May 16, 2022	SELL	$1.85 - $4.59 $8,552 - $21,219	-4,623 Reduced 48.79%	4,852 $10,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.74 $3,364 - $8,288	-1,444 Reduced 13.22%	9,475 $43,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $11.26 $23,348 - $43,745	3,885 Added 55.23%	10,919 $66,000
Q2 2021 Aug 16, 2021	BUY	$10.12 - $17.46 $49,183 - $84,855	4,860 Added 223.55%	7,034 $79,000
Q1 2021 May 13, 2021	SELL	$14.8 - $25.79 $22,940 - $39,974	-1,550 Reduced 41.62%	2,174 $36,000
Q4 2020 Feb 09, 2021	BUY	$15.38 - $32.42 $57,275 - $120,732	3,724 New	3,724 $90,000

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $11.5M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.